Fibroblast Growth Factor 23 and Left Ventricular Hypertrophy in Chronic Kidney Disease—A Pediatric Perspective

Cardiovascular diseases (CVD) are a hallmark in pediatric patients with chronic kidney disease (CKD) contributing to an enhanced risk of all-cause and CV morbidity and mortality in these patients. The bone-derived phosphaturic hormone fibroblast growth factor (FGF) 23 progressively rises with declin...

Descripción completa

Detalles Bibliográficos
Autores principales: Grund, Andrea, Sinha, Manish D., Haffner, Dieter, Leifheit-Nestler, Maren
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pediatrics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8372151/
https://www.ncbi.nlm.nih.gov/pubmed/34422725
http://dx.doi.org/10.3389/fped.2021.702719

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8372151/
https://www.ncbi.nlm.nih.gov/pubmed/34422725
http://dx.doi.org/10.3389/fped.2021.702719

Ejemplares similares